@inproceedings{zhang-etal-2024-ynu,
title = "{YNU}-{HPCC} at {S}em{E}val-2024 Task 2: Applying {D}e{BERT}a-v3-large to Safe Biomedical Natural Language Inference for Clinical Trials",
author = "Zhang, Rengui and
Wang, Jin and
Zhang, Xuejie",
editor = {Ojha, Atul Kr. and
Do{\u{g}}ru{\"o}z, A. Seza and
Tayyar Madabushi, Harish and
Da San Martino, Giovanni and
Rosenthal, Sara and
Ros{\'a}, Aiala},
booktitle = "Proceedings of the 18th International Workshop on Semantic Evaluation (SemEval-2024)",
month = jun,
year = "2024",
address = "Mexico City, Mexico",
publisher = "Association for Computational Linguistics",
url = "https://aclanthology.org/2024.semeval-1.112",
doi = "10.18653/v1/2024.semeval-1.112",
pages = "785--791",
abstract = "This paper describes the system for the YNU-HPCC team for SemEval2024 Task 2, focusing on Safe Biomedical Natural Language Inference for Clinical Trials. The core challenge of this task lies in discerning the textual entailment relationship between Clinical Trial Reports (CTR) and statements annotated by expert annotators, including the necessity to infer the relationships in texts subjected to semantic interventions accurately. Our approach leverages a fine-tuned DeBERTa-v3-large model augmented with supervised contrastive learning and back-translation techniques. Supervised contrastive learning aims to bolster classification ac-curacy while back-translation enriches the diversity and quality of our training corpus. Our method achieves a decent F1 score. However, the results also indicate a need for further en-hancements in the system{'}s capacity for deep semantic comprehension, highlighting areas for future refinement. The code of this paper is available at:https://github.com/RGTnuw/RG{\_}YNU-HPCC-at-Semeval2024-Task2.",
}
<?xml version="1.0" encoding="UTF-8"?>
<modsCollection xmlns="http://www.loc.gov/mods/v3">
<mods ID="zhang-etal-2024-ynu">
<titleInfo>
<title>YNU-HPCC at SemEval-2024 Task 2: Applying DeBERTa-v3-large to Safe Biomedical Natural Language Inference for Clinical Trials</title>
</titleInfo>
<name type="personal">
<namePart type="given">Rengui</namePart>
<namePart type="family">Zhang</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Jin</namePart>
<namePart type="family">Wang</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Xuejie</namePart>
<namePart type="family">Zhang</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<originInfo>
<dateIssued>2024-06</dateIssued>
</originInfo>
<typeOfResource>text</typeOfResource>
<relatedItem type="host">
<titleInfo>
<title>Proceedings of the 18th International Workshop on Semantic Evaluation (SemEval-2024)</title>
</titleInfo>
<name type="personal">
<namePart type="given">Atul</namePart>
<namePart type="given">Kr.</namePart>
<namePart type="family">Ojha</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A</namePart>
<namePart type="given">Seza</namePart>
<namePart type="family">Doğruöz</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Harish</namePart>
<namePart type="family">Tayyar Madabushi</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Giovanni</namePart>
<namePart type="family">Da San Martino</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Sara</namePart>
<namePart type="family">Rosenthal</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Aiala</namePart>
<namePart type="family">Rosá</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<originInfo>
<publisher>Association for Computational Linguistics</publisher>
<place>
<placeTerm type="text">Mexico City, Mexico</placeTerm>
</place>
</originInfo>
<genre authority="marcgt">conference publication</genre>
</relatedItem>
<abstract>This paper describes the system for the YNU-HPCC team for SemEval2024 Task 2, focusing on Safe Biomedical Natural Language Inference for Clinical Trials. The core challenge of this task lies in discerning the textual entailment relationship between Clinical Trial Reports (CTR) and statements annotated by expert annotators, including the necessity to infer the relationships in texts subjected to semantic interventions accurately. Our approach leverages a fine-tuned DeBERTa-v3-large model augmented with supervised contrastive learning and back-translation techniques. Supervised contrastive learning aims to bolster classification ac-curacy while back-translation enriches the diversity and quality of our training corpus. Our method achieves a decent F1 score. However, the results also indicate a need for further en-hancements in the system’s capacity for deep semantic comprehension, highlighting areas for future refinement. The code of this paper is available at:https://github.com/RGTnuw/RG_YNU-HPCC-at-Semeval2024-Task2.</abstract>
<identifier type="citekey">zhang-etal-2024-ynu</identifier>
<identifier type="doi">10.18653/v1/2024.semeval-1.112</identifier>
<location>
<url>https://aclanthology.org/2024.semeval-1.112</url>
</location>
<part>
<date>2024-06</date>
<extent unit="page">
<start>785</start>
<end>791</end>
</extent>
</part>
</mods>
</modsCollection>
%0 Conference Proceedings
%T YNU-HPCC at SemEval-2024 Task 2: Applying DeBERTa-v3-large to Safe Biomedical Natural Language Inference for Clinical Trials
%A Zhang, Rengui
%A Wang, Jin
%A Zhang, Xuejie
%Y Ojha, Atul Kr.
%Y Doğruöz, A. Seza
%Y Tayyar Madabushi, Harish
%Y Da San Martino, Giovanni
%Y Rosenthal, Sara
%Y Rosá, Aiala
%S Proceedings of the 18th International Workshop on Semantic Evaluation (SemEval-2024)
%D 2024
%8 June
%I Association for Computational Linguistics
%C Mexico City, Mexico
%F zhang-etal-2024-ynu
%X This paper describes the system for the YNU-HPCC team for SemEval2024 Task 2, focusing on Safe Biomedical Natural Language Inference for Clinical Trials. The core challenge of this task lies in discerning the textual entailment relationship between Clinical Trial Reports (CTR) and statements annotated by expert annotators, including the necessity to infer the relationships in texts subjected to semantic interventions accurately. Our approach leverages a fine-tuned DeBERTa-v3-large model augmented with supervised contrastive learning and back-translation techniques. Supervised contrastive learning aims to bolster classification ac-curacy while back-translation enriches the diversity and quality of our training corpus. Our method achieves a decent F1 score. However, the results also indicate a need for further en-hancements in the system’s capacity for deep semantic comprehension, highlighting areas for future refinement. The code of this paper is available at:https://github.com/RGTnuw/RG_YNU-HPCC-at-Semeval2024-Task2.
%R 10.18653/v1/2024.semeval-1.112
%U https://aclanthology.org/2024.semeval-1.112
%U https://doi.org/10.18653/v1/2024.semeval-1.112
%P 785-791
Markdown (Informal)
[YNU-HPCC at SemEval-2024 Task 2: Applying DeBERTa-v3-large to Safe Biomedical Natural Language Inference for Clinical Trials](https://aclanthology.org/2024.semeval-1.112) (Zhang et al., SemEval 2024)
ACL